title: [The use of valdoxan in the treatment of post-stroke depression].
abstract: Forty patients, aged from 55 to 85 years, with post-stroke depression received valdoxan in dosage of 25 mg daily during 3 months. Patient's state was assessed with a battery of scales (The Hamilton depression scale, MMSE, Tinnetti scale etc). The high antidepressive effect and good tolerability of the drug were demonstrated. The improvement of movement and cognitive functions, together with the stabilization of the emotional state, was seen.
authors.forename: A N
authors.initials: AN
authors.lastname: Bogolepova
authors.forename: E I
authors.initials: EI
authors.lastname: Chukanova
authors.forename: M Iu
authors.initials: MIu
authors.lastname: Smirnova
authors.forename: A S
authors.initials: AS
authors.lastname: Chukanova
authors.forename: I Iu
authors.initials: IIu
authors.lastname: Gracheva
authors.forename: E G
authors.initials: EG
authors.lastname: Semushkina
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects; D003863:Depression / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D004334:Drug Administration Schedule; D004644:Emotions / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D020521:Stroke / Q000150:complications*; D009281:Naphthalenes
chemical_list: D000081:Acetamides; D000928:Antidepressive Agents; C084711:agomelatine; D009281:Naphthalenes